Right. That's at least a partial explanation for the survey results.
p.s. The upper age bounds (different for men and women) in the labels for Gardasil and Cervarix seem unduly low, even though they are a consequence of the patient pools enrolled in the clinical trials.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.